NCT04039139

Brief Summary

Chronic pain syndromes without identified organic etiology remain a challenge for physicians. Many syndromes, including back pain, are believed to have potential underlying psychological etiology; however, the exact link remains elusive. The goal of this study is to determine if mind body therapies can help people suffering from chronic back pain. The study is a randomized, partially blinded trial examining the effectiveness of Mind Body Syndrome Therapy (MBST) in reducing disability from back pain and alleviating back pain. The investigators will secondarily investigate whether MBST can improve participant quality of life and reduce the need for pain-related hospitalization. The design of the this study consists of 3 arms with one being the intervention (MBST), one being usual care, and one being a second mind-body intervention (active control). This education program consists of a series of personal interviews and group and/or individualized lectures/sessions. Participants will also be provided reading material to study during the intervention period, and asked to continue their usual care while going through the MBST program.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
35

participants targeted

Target at P25-P50 for not_applicable chronic-pain

Timeline
Completed

Started Jul 2019

Shorter than P25 for not_applicable chronic-pain

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 29, 2019

Completed
1 day until next milestone

Study Start

First participant enrolled

July 30, 2019

Completed
1 day until next milestone

First Posted

Study publicly available on registry

July 31, 2019

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 20, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 20, 2020

Completed
Last Updated

January 11, 2023

Status Verified

January 1, 2023

Enrollment Period

9 months

First QC Date

July 29, 2019

Last Update Submit

January 10, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Pain Disability: Roland Morris Disability Index

    Change in the Roland Morris Disability Index (Scale 0-24 with 24 being worst)

    change over 26 weeks

Secondary Outcomes (7)

  • Average Pain: Brief Pain Inventory Survey

    4 weeks, 8 weeks, 13, weeks, 26 weeks

  • Pain Bothersomeness (Back Specific): Brief Pain Inventory Survey

    4 weeks, 8 weeks, 13 weeks, 26 weeks

  • Pain Bothersomeness: Brief Pain Inventory Survey

    4 weeks, 8 weeks, 13 weeks, 26 weeks

  • Pain affecting enjoyment of life

    4 weeks, 8 weeks, 13 weeks, 26 weeks

  • Anxiety from pain: Pain Anxiety Symptom Scale-20 survey

    4 weeks, 8 weeks, 13 weeks, 26 weeks

  • +2 more secondary outcomes

Study Arms (3)

Usual Care

NO INTERVENTION

Participants will continue their usual care for 26 weeks

Mind Body Intervention 1: Mind-Body-Syndrome-Therapy (MBST)

EXPERIMENTAL

Participants will receive a mind body educational-based intervention to learn the techniques comprising intervention 1. Further details are not provided for blinding purposes.

Behavioral: Mind Body Intervention 1: Mind-Body-Syndrome-Therapy (MBST)

Mind Body Intervention 2

ACTIVE COMPARATOR

Participants will receive a mind-body educational-based intervention to learn the techniques comprising intervention 2. Further details are not provided for blinding purposes.

Behavioral: Mind Body Intervention 2

Interventions

Mind body techniques for Intervention 1 will be taught in lectures and group discussion sessions.

Also known as: MBST
Mind Body Intervention 1: Mind-Body-Syndrome-Therapy (MBST)

Mind body techniques for Intervention 2 will be taught in lectures and group and/or individual sessions.

Mind Body Intervention 2

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult patient 18 \> years old
  • Chronic back pain
  • Pain persistent for ≥3 days/week for the past 3 months prior to enrollment
  • Willingness to consider mind-body intervention

You may not qualify if:

  • Patients \< 18 years of age
  • Patients with a diagnosis of significant psychiatric co-morbidities such as schizophrenia, dementia and bipolar disorder.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Beth Israel Deaconess Medical Center

Boston, Massachusetts, 02215, United States

Location

MeSH Terms

Conditions

Chronic Pain

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Michael Donnino, MD

    Beth Israel Deaconess Medical Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
Participants will be partially blinded. Participants in the usual care arm will be blinded to the specifics of the interventions. Intervention participants will be blinded to the specifics of the intervention until after they have been randomized into that arm. Data analysis will be conducted by persons who are completely blinded.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Usual Care, Intervention
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor of Emergency Medicine

Study Record Dates

First Submitted

July 29, 2019

First Posted

July 31, 2019

Study Start

July 30, 2019

Primary Completion

April 20, 2020

Study Completion

April 20, 2020

Last Updated

January 11, 2023

Record last verified: 2023-01

Data Sharing

IPD Sharing
Will not share

The investigators will not be sharing IPD data with researchers outside of their research group.

Locations